Broomfield, CO, United States of America

Scott Alan Pratt

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Boulder, CO (US) (2010 - 2012)
  • Broomfield, CO (US) (2009 - 2016)

Company Filing History:


Years Active: 2009-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Scott Alan Pratt: A Visionary Inventor

Introduction

Scott Alan Pratt, a distinguished inventor based in Broomfield, Colorado, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of four patents, his work primarily revolves around the development of novel compounds aimed at enhancing therapeutic efficacy. Pratt's contributions have been integral to advancements in receptor modulation and antagonist development, reshaping medicinal chemistry.

Latest Patents

Scott Alan Pratt's latest patent focuses on "Substituted pyrazolo[1,5-A] pyrimidines as calcium receptor modulating agents." This innovative patent introduces a calcium receptor modulator comprising a complex structure defined by specific formulas involving various rings, heterocycles, and substituents. The intricate details of the compound's formula (I) emphasize the nuanced approach Pratt takes in his inventions.

Additionally, another significant patent by Pratt involves "Fused heterocyclic compounds," which presents a CRF receptor antagonist. This patent showcases a compound designed with intricate structures, where various components, including hydrocarbyl and heteroaryl groups, play pivotal roles in its functionality. The complexities of the compounds underscore Pratt’s expertise and dedication to innovation in pharmacology.

Career Highlights

Scott Alan Pratt is currently affiliated with Takeda Pharmaceutical Company Limited, where he continues to push the boundaries of pharmaceutical research and development. His role at Takeda allows him to work at the forefront of innovation, contributing his expertise to the development of therapeutic agents that promise to improve patient outcomes.

Collaborations

Pratt has collaborated with esteemed colleagues, including Albert Charles Gyorkos and Christopher Peter Corrette. These collaborations reflect a synergistic approach to research and development, combining diverse expertise to tackle complex scientific challenges in the pharmaceutical landscape.

Conclusion

Scott Alan Pratt stands out as a notable inventor whose contributions continue to influence the pharmaceutical industry. His advanced understanding of chemical compounds and their applications has led to innovative patents that promise to shape future research and therapy. With a commitment to excellence and collaboration, Pratt exemplifies the impact that dedicated inventors can have on science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…